DSDmitry Alekseevich Soldatov

Dmitry Alekseevich Soldatov

*This is an algorithmically generated author record based on publicly available information.

Dmitry Alekseevich Soldatov has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Construction and study of the properties of a veterinary medicine based on silymarin and gold nanoparticles

    by Dmitry Alekseevich Soldatov, Natalia Igorevna Skvortsova, Anna Dmitrievna Klyukina, Mikhail Andreevich Chekunov, Ekaterina Dmitrievna Chekunova

    Research on nanomaterials is currently very promising, thanks to them we can deliver the necessary substance, bypassing the barriers of the body. Silymarin has an anti-inflammatory effect due to its antioxidant properties, which have been repeatedly confirmed by experiments. The work was carried out on the basis of the Department of "Animal Diseases and VSE" and the CCP "Molecular Biology" of the Vavilov University. The work consisted of several stages, where we synthesized the drug silymarin-gnp, obtained polyclonal antibodies for silymarin, and carried out antibody labeling. And they were engaged in the detection of silymarin in the cells of the reticuloendothelial system. Thus, the study of the created conjugate of silymarin and colloidal gold nanoparticles made it possible to determine that animals immunized with the resulting drug are able to produce antibodies to it, and the sizes of nanoparticles in it do not exceed 20-23 nm.

  • Open Access

    Immunization of Mice with Gold Nanoparticles Conjugated to Thermostable Cancer Antigens Prevents the Development of Xenografted Tumors

    by Lev A. Dykman, Sergey A. Staroverov, Sergey V. Kozlov, Alexander S. Fomin, Daniil S. Chumakov, Konstantin P. Gabalov, Yevgeny S. Kozlov, Dmitry A. Soldatov, Nikolai G. Khlebtsov

    Gold nanoparticles as part of vaccines greatly increase antigen stability, antigen accumulation in the lymph nodes, and antigen uptake by antigen-presenting cells. The use of such particles as part of anticancer vaccines based on heat shock proteins to increase vaccine effectiveness is timely. We prepared and characterized nanoconjugates based on 15-nm gold nanoparticles and thermostable tumor antigens isolated from MH22a murine hepatoma cells. The whole-cell lysate of MH22a cells contained the main heat shock proteins. BALB/c mice were injected with the conjugates and then received transplants of MH22a cells. The highest titer was produced in mice immunized with the complex of gold nanoparticles + antigen with complete Freund’s adjuvant. The immunized mice showed no signs of tumor growth for 24 days. They also showed a decreased production of the INF-γ, IL-6, and IL-1 proinflammatory cytokines compared to the mice immunized through other schemes. This study is the first to show that it is possible in principle to use gold nanoparticles in combination with thermostable tumor antigens for antitumor vaccination. Antitumor vaccines based on thermostable tumor antigens can be largely improved by including gold nanoparticles as additional adjuvants.


  • Open Access

    Immunization of mice with gold nanoparticles conjugated to thermostable tumor antigens prevents tumor development during transplantation

    by Sergey A Staroverov, Sergey V. Kozlov, Alexander S. Fomin, Daniil S. Chumakov, Konstantin P. Gabalov, Yevgeny S. Kozlov, Dmitry A Soldatov, Lev A Dykman

    Gold nanoparticles as part of vaccines greatly increase antigen stability, antigen accumulation in the lymph nodes, and antigen uptake by antigen-presenting cells. The use of such particles as part of anticancer vaccines based on heat shock proteins to increase vaccine effectiveness is timely. We prepared and characterized nanoconjugates based on 15-nm gold nanoparticles and thermostable tumor antigens isolated from MH22a murine hepatoma cells. BALB/c mice were injected with the conjugates and then received transplants of MH22a cells. The immunized mice showed no signs of tumor growth for 24 days. They also showed decreased production of the INF-γ, IL-6, and IL-1 proinflammatory cytokines, as compared to the mice immunized through other schemes. This study is the first to show that it is possible in principle to use gold nanoparticles in combination with thermostable tumor antigens for antitumor vaccination. Antitumor vaccines based on thermostable tumor antigens can be largely improved by including gold nanoparticles as additional adjuvants.